InfuSystems Holdings (InfuSystems Holdings) Days Sales Outstanding : 56.42 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Days Sales Outstanding?

InfuSystems Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $19.6 Mil. InfuSystems Holdings's Revenue for the three months ended in Dec. 2023 was $31.8 Mil. Hence, InfuSystems Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 56.42.

The historical rank and industry rank for InfuSystems Holdings's Days Sales Outstanding or its related term are showing as below:

INFU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.8 Med: 55.23 Max: 62.66
Current: 54.14

During the past 13 years, InfuSystems Holdings's highest Days Sales Outstanding was 62.66. The lowest was 48.80. And the median was 55.23.

INFU's Days Sales Outstanding is ranked better than
62.95% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.21 vs INFU: 54.14

InfuSystems Holdings's Days Sales Outstanding increased from Dec. 2022 (52.20) to Dec. 2023 (56.42).

InfuSystems Holdings Days Sales Outstanding Historical Data

The historical data trend for InfuSystems Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Days Sales Outstanding Chart

InfuSystems Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

48.80

50.25

53.70

53.59

53.25

InfuSystems Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															52.20	52.79	53.39	54.80	56.42

Competitive Comparison of InfuSystems Holdings's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InfuSystems Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Days Sales Outstanding falls into.

InfuSystems Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

InfuSystems Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (16.871	+	19.83)	/	2 )	/	125.785	*	365
=	18.3505					/	125.785	*	365
=	53.25

InfuSystems Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (19.455	+	19.83)	/	2 )	/	31.771	*	365 / 4
=	19.6425					/	31.771	*	365 / 4
=	56.42

InfuSystems Holdings (AMEX:INFU) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

InfuSystems Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings (InfuSystems Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

1TZ:Germany

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

Executives

Jerod Funke	officer: EVP-Chief HR Officer	3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra	director	C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman	director	309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio	officer: Executive Vice President	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele	officer: Executive VP and CFO	500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance	officer: Executive VP and COO	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone	director	C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa	officer: Executive VP and CIO	3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman	officer: VP and Corporate Controller	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz	officer: VP of Sales and Marketing	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr	director
Paul Andrew Gendron	director	740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan	officer: Chief Administrative Officer	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p.	director	3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp	10 percent owner	405 WEED STREET, NEW CANAAN CT 06840